Sodium and risk assessment of osmotic demyelination syndrome: the method matters!
Clin Chem Lab Med
.
2023 Jul 27;62(1):e22-e23.
doi: 10.1515/cclm-2023-0667.
Print 2024 Jan 26.
Authors
Veronique V Stove
1
,
Matthijs Oyaert
1
,
Joris R Delanghe
1
Affiliation
1
Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
PMID:
37493176
DOI:
10.1515/cclm-2023-0667
No abstract available
Keywords:
covolume; potentiometry; sodium.
Publication types
Letter
Comment
MeSH terms
Demyelinating Diseases* / diagnosis
Humans
Hyponatremia* / diagnosis
Risk Assessment
Sodium
Substances
Sodium